loadpatents
Patent applications and USPTO patent grants for Moser; Heinz Ernst.The latest application filed is for "antibacterial aminoglycoside analogs".
Patent | Date |
---|---|
Antibacterial aminoglycoside analogs Grant 11,117,915 - Aggen , et al. September 14, 2 | 2021-09-14 |
Salts and solid forms of a monobactam antibiotic Grant 10,919,887 - Aubin , et al. February 16, 2 | 2021-02-16 |
Antibacterial Aminoglycoside Analogs App 20200317709 - Aggen; James Bradley ;   et al. | 2020-10-08 |
Monobactam Organic Compounds For The Treatment Of Bacterial Infections App 20200276169 - AULAKH; Virender Singh ;   et al. | 2020-09-03 |
Monobactam organic compounds for the treatment of bacterial infections Grant 10,369,138 - Aulakh , et al. | 2019-08-06 |
Monobactam Organic Compounds For The Treatment Of Bacterial Infections App 20190231752 - AULAKH; Virender Singh ;   et al. | 2019-08-01 |
Tricyclic 2-quinolinones As Antibacterials App 20180318311 - LAPOINTE; Guillaume ;   et al. | 2018-11-08 |
Salts And Solid Forms Of A Monobactam Antibiotic App 20180273522 - AUBIN; Eric ;   et al. | 2018-09-27 |
Antibacterial aminoglycoside analogs Grant 9,688,711 - Aggen , et al. June 27, 2 | 2017-06-27 |
Antibacterial Agents App 20170088549 - MOSER; Heinz Ernst ;   et al. | 2017-03-30 |
Antibacterial Aminoglycoside Analogs App 20160368942 - Aggen; James Bradley ;   et al. | 2016-12-22 |
Monobactam Organic Compounds For The Treatment Of Bacterial Infections App 20160051523 - AULAKH; Virender Singh ;   et al. | 2016-02-25 |
Antibacterial aminoglycoside analogs Grant 9,266,919 - Aggen , et al. February 23, 2 | 2016-02-23 |
Monobactam organic compounds for the treatment of bacterial infections Grant 9,174,978 - Aulakh , et al. November 3, 2 | 2015-11-03 |
Monobactam Organic Compounds For The Treatment Of Bacterial Infections App 20150266867 - AULAKH; Virender Singh ;   et al. | 2015-09-24 |
Antibacterial Aminoglycoside Analogs App 20150045317 - Aggen; James Bradley ;   et al. | 2015-02-12 |
Antibacterial aminoglycoside analogs Grant 8,822,424 - Aggen , et al. September 2, 2 | 2014-09-02 |
Antibacterial Aminoglycoside Analogs App 20130217642 - Aggen; James Bradley ;   et al. | 2013-08-22 |
Antibacterial aminoglycoside analogs Grant 8,383,596 - Aggen , et al. February 26, 2 | 2013-02-26 |
Antibacterial aminoglycoside analogs Grant 8,372,813 - Aggen , et al. February 12, 2 | 2013-02-12 |
Antibacterial aminoglycoside analogs Grant 8,367,625 - Aggen , et al. February 5, 2 | 2013-02-05 |
Antibacterial Aminoglycoside Analogs App 20120172332 - Aggen; James Bradley ;   et al. | 2012-07-05 |
Antibacterial Aminoglycoside Analogs App 20110288041 - Aggen; James Bradley ;   et al. | 2011-11-24 |
Carbacephem Beta-lactam Antibiotics App 20110224186 - Wagman; Allan Scott ;   et al. | 2011-09-15 |
Antibacterial Aminoglycoside Analogs App 20100099661 - Aggen; James Bradley ;   et al. | 2010-04-22 |
Antibacterial 1,4,5-substituted Aminoglycoside Analogs App 20080300199 - Linsell; Martin ;   et al. | 2008-12-04 |
2'-Substituted nucleosides and oligonucleotide derivatives App 20050159374 - Cuenoud, Bernard ;   et al. | 2005-07-21 |
2'-substituted nucleosides and oligonucleotide derivatives Grant 6,670,468 - Cuenoud , et al. December 30, 2 | 2003-12-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.